In the attempt to reduce inflammation and oxidative stress, statins may also be extremely effective (though always in a combinatorial treatment), as they have been reported to inhibit MPN cell proliferation and augment the action of JAK2 inhibition [3,10]. The gene discussed is JAK2; the disease is myeloproliferative neoplasm.